forecast

Incentives Could Stall Fundamental Research

Alex worries that if innovation incentives weaken, companies will stop investing in fundamental, decade-long research, instead marketing old drugs, extending patents, and investing in hard-to-copy products like radiotherapeutics and CAR Ts.

forecastpending

Speaker

Alex

Evidence Quote

“And then you're just going to sit on existing treatments and try to milk them as much as possible and use tricks and techniques to extend the patent life”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...